- Home
- QNTM vs GROW Comparison
QNTM vs GROW Comparison
Compare QNTM & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNTM
- GROW
- Stock Information
- Founded
- QNTM 1998
- GROW 1968
- Country
- QNTM Canada
- GROW United States
- Employees
- QNTM N/A
- GROW 26
- Industry
- QNTM
- GROW Investment Managers
- Sector
- QNTM
- GROW Finance
- Exchange
- QNTM NYSE
- GROW Nasdaq
- Market Cap
- QNTM 35.6M
- GROW 31.8M
- IPO Year
- QNTM N/A
- GROW N/A
- Fundamental
- Price
- QNTM $21.02
- GROW $2.48
- Analyst Decision
- QNTM
- GROW
- Analyst Count
- QNTM 0
- GROW 0
- Target Price
- QNTM N/A
- GROW N/A
- AVG Volume (30 Days)
- QNTM 414.2K
- GROW 27.8K
- Earning Date
- QNTM 08-13-2025
- GROW 05-08-2025
- Dividend Yield
- QNTM N/A
- GROW 3.69%
- EPS Growth
- QNTM N/A
- GROW N/A
- EPS
- QNTM N/A
- GROW 0.01
- Revenue
- QNTM N/A
- GROW $8,932,000.00
- Revenue This Year
- QNTM N/A
- GROW N/A
- Revenue Next Year
- QNTM N/A
- GROW N/A
- P/E Ratio
- QNTM N/A
- GROW $228.61
- Revenue Growth
- QNTM N/A
- GROW N/A
- 52 Week Low
- QNTM $2.70
- GROW $2.02
- 52 Week High
- QNTM $38.25
- GROW $2.73
- Technical
- Relative Strength Index (RSI)
- QNTM 54.17
- GROW 68.20
- Support Level
- QNTM $20.89
- GROW $2.30
- Resistance Level
- QNTM $38.25
- GROW $2.45
- Average True Range (ATR)
- QNTM 4.22
- GROW 0.07
- MACD
- QNTM 0.15
- GROW 0.00
- Stochastic Oscillator
- QNTM 34.92
- GROW 97.37
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.